A61P 27/12
For cataracts
Official title: for cataracts
A61P27/12 (For cataracts) appears on 1,260 US grants and 1,931 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,260
- Published applications
- 1,931
- Assignees
- 843
- Inventors
- 3,591
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 8 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 8 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 7 | 0 |
| 1995 | 2 | 0 |
| 1996 | 11 | 0 |
| 1997 | 6 | 0 |
| 1998 | 13 | 0 |
| 1999 | 14 | 0 |
| 2000 | 16 | 0 |
| 2001 | 19 | 6 |
| 2002 | 26 | 28 |
| 2003 | 30 | 64 |
| 2004 | 26 | 80 |
| 2005 | 17 | 84 |
| 2006 | 25 | 70 |
| 2007 | 31 | 107 |
| 2008 | 29 | 104 |
| 2009 | 37 | 99 |
| 2010 | 62 | 165 |
| 2011 | 64 | 142 |
| 2012 | 67 | 123 |
| 2013 | 88 | 90 |
| 2014 | 88 | 103 |
| 2015 | 86 | 88 |
| 2016 | 66 | 97 |
| 2017 | 64 | 92 |
| 2018 | 54 | 76 |
| 2019 | 66 | 56 |
| 2020 | 38 | 63 |
| 2021 | 46 | 54 |
| 2022 | 24 | 39 |
| 2023 | 24 | 33 |
| 2024 | 24 | 29 |
| 2025 | 14 | 24 |
| 2026 | 12 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Eye drops with citric acid as the sole active ingredient11 Aug 2026US 12,702,653 B2
- Diacylglycerol acyl transferase 2 inhibitors11 Aug 2026US 12,703,696 B2Pfizer Inc.
- Compounds and formulations for treating ophthalmic diseases26 May 2026US 12,637,425 B2Visus Therapeutics, Inc.
- Specification of functional cranial placode derivatives from human pluripotent stem cells5 May 2026US 12,618,044 B2Memorial Sloan Kettering Cancer Center
- Bioactive supplement21 Apr 2026US 12,605,357 B2
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Lipid nanoparticles for the treatment of ocular diseases13 Aug 2026US 2026/0232590 A1
- Ophthalmic composition for ocular surgery preparation in patients with ocular surface disease13 Aug 2026US 2026/0232757 A1
- Inhibitors of tryptophan dioxygenases (ido1 and tdo) and their use in therapy6 Aug 2026US 2026/0224586 A1Auckland Uniservices Limited
- Processes for making cyclic lipid implants for intraocular use16 Jul 2026US 2026/0199242 A1Allergan, Inc.
Most cited
By later US patents
- Methods of ophthalmic administration187US 6,378,526 B1Insite Vision Incorporated · 2002
- Methods of ophthalmic administration127US 6,397,849 B1Insite Vision Incorporated · 2002
- Mediators of hedgehog signaling pathways, compositions and uses related thereto127US 6,545,005 B1Curtis, Inc. · 2003
- Conveniently implantable sustained release drug compositions126US 7,906,136 B2Ramscor, Inc. · 2011
- Chemically modified oligonucleotides123US 7,582,744 B2Alnylam Pharmaceuticals, Inc. · 2009